4/5 and ancestral SARS-CoV-2 than mRNA-1273, with the highest geometric mean titer ratios observed in adults and in the subset of participants aged 65 years and older,” Moderna said. The new ...

In a record-breaking span of just 11 months, Moderna created, developed, manufactured, and got regulatory authorization for mRNA-1273, a two-dose covid vaccine that is one of the first two mRNA ...

4/BA.5 and original strains, when compared to mRNA-1273.222. "Moderna blamed after children offered £1,500 to take part in Covid-19 trial " was originally created and published by Clinical Trials ...

Three-month data will be reported later this summer. "We are thrilled to share the preliminary data analysis on mRNA-1273.214," said Moderna's chief executive Stéphane Bancel, who added that the ...

Investigators from NIAID and Moderna co-developed the mRNA-1273 vaccine, which is currently authorized by the Food and Drug Administration (FDA) for emergency use in the United States for the ...

“We are also focused on responding to the pandemic through our work on our vaccine candidate against COVID-19, mRNA-1273. We are grateful to everyone both inside and outside Moderna who is ...

This study evaluated a two-dose vaccination schedule of Moderna 's Covid-19 vaccine candidate mRNA-1273 given 28 days apart in 40 healthy adult participants across two dose levels -- 25 and 100 ...

The Moderna laboratories Tuesday reported that their two bivalent Omicron-targeting new messenger RNA (mRNA) technology booster vaccines (mRNA-1273.214 and mRNA-1273.222) have a superior antibody ...